JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 53(2019) N 3 p. 427-437; DOI 10.1134/S0026893319030129 Full Text

D.A. Mogilenko1,2,3, V.S. Shavva1, E.B. Dizhe1, S.V. Orlov1,2*

Characterization of Distal and Proximal Alternative Promoters of the Human ApoA-I Gene

1Institute of Experimental Medicine, St. Petersburg, 197376 Russia
2St. Petersburg State University, St. Petersburg, 199034 Russia
3Universite de Lille, Inserm, Institut Pasteur de Lille, U1011-EGID, Lille, 59000 France

*serge@iem.sp.ru
Received - 2018-12-09; Revised - 2018-12-29; Accepted - 2018-12-29

Human apolipoprotein A-I (ApoA-I) is a major structural and functional protein component of high-density lipoprotein (HDL). ApoA-I constitutes ~75% of the protein content of HDL. The main sites of ApoA-I synthesis in humans are the liver and the small intestine. The mechanisms that govern tissue-specific apoA-I transcription in tissues and organs other than the liver and the small intestine are poorly understood. It is known that the human apoA-I has two additional promoters, the proximal and the distal one. In this work these two alternative apoA-I promoters are characterized, their transcription start sites are mapped and their competition for apoA-Itranscription is demonstrated; the role of the alternative promoters in apoA-I expression in human cells and tissues other than hepatocytes and enterocytes is discussed.

apolipoprotein A-I, alternative promoter, promoter competition, transcription start site, human hepatoma cells HepG2



JMB-FOOTER RAS-JOURNALS